Scarica l'app Stockscreener
1.18
4.84%
-0.06
Marker Therapeutics Inc Borsa (MRKR) Ultime notizie
H.C. Wainwright reiterates Marker Therapeutics stock rating at buy By Investing.com - Investing.com India
US High Growth Tech Stocks To Watch In August 2026 - simplywall.st
Marker Therapeutics (MRKR) Rises 1.75%, Holding Above Key $1.10 SupportIchimoku Kumo Twist - vinanet.vn
Marker Therapeutics Stock Price Forecast. Should You Buy MRKR? - StockInvest.us
Marker Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
MRKR Advances 2.7% to $1.14 as Biotech Stock Holds Above Key SupportVanna Flow - Vinanet
Marker Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CCORF Maintains Marker Therapeutics(MRKR.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Stock List: Research Stocks from Around the World - GuruFocus
Marker Therapeutics Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Marker Therapeutics Inc (MRKR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MRKR Q1 2026 Earnings: Narrower-Than-Expected Loss of $0.16 Per Share Marks 14.44% EPS SurpriseProfit Inflection Point - vinanet.vn
MRKR Q1 2026 Earnings: Narrower Loss Beats Estimates as Investors Focus on Clinical MilestonesGuidance Downgrade Alert - vinanet.vn
Marker Therapeutics, Inc. Revenue Breakdown – NASDAQ:MRKR - TradingView
Marker Therapeutics Inc (MRKR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Marker Therapeutics Inc (MRKR) Balance Sheet - TradingKey
Marker Therapeutics Inc (MRKR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Marker Therapeutics Inc (MRKR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Marker Therapeutics Inc (MRKR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TradingKey - TradingKey
MRKR|Marker Therapeutics Inc|Price:1.200|Chg%:-0.020 - TradingKey
MRKR|Marker Therapeutics Inc|Price:1.220|Chg%:-0.050 - TradingKey
Marker Therapeutics Inc (MRKR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
US High Growth Tech Stocks to Watch for Potential Expansion - simplywall.st
High Growth Tech Stocks In The US Market - simplywall.st
Exploring High Growth Tech Stocks In The US For July 2026 - simplywall.st
MRKR Q1 2026 Earnings: Narrower Loss Beats Estimates as Pipeline Progress ContinuesGuidance Revision Trend - Vinanet
MRKR Q1 2026 Earnings: Narrower Loss Slightly Beats Expectations as Stock SlipsRevenue Warning Signal - vinanet.vn
Marker Therapeutics (MRKR) Slips 4.43% as Biotech Struggles, Holds Above $1.43 SupportBreakout Confirmation - dars.gov.et
Wainwright reiterates Buy on Marker Therapeutics stock, $10 target By Investing.com - Investing.com Canada
Wainwright reiterates Buy on Marker Therapeutics stock, $10 target - Investing.com
MSN Money - MSN
Marker Therapeutics, Inc.'s (NASDAQ:MRKR) Profit Outlook - simplywall.st
MRKR Q1 2026 Earnings: Narrower Loss Surpasses ExpectationsRevenue Growth Outlook - dars.gov.et
US High Growth Tech Stocks to Watch - simplywall.st
Marker Therapeutics Surges 11%: Key Levels and Potential Catalysts in FocusStandard Deviation - dars.gov.et
Exploring 3 High Growth Tech Stocks in the US Market - simplywall.st
Price to earnings forward of Marker Therapeutics, Inc. – NASDAQ:MRKR - TradingView
Marker Therapeutics Inc. (MRKR) Posts Modest Gain as Shares Approach Key ResistanceCash Flow Strong Stocks - dars.gov.et
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail
MRKR Forecast — Price Target — Prediction for 2027 - TradingView
Marker Therapeutics, Inc. Actuals & Estimates (NASDAQ:MRKR) - TradingView
Price to sales forward of Marker Therapeutics, Inc. – NASDAQ:MRKR - TradingView
Price to book forward of Marker Therapeutics, Inc. – NASDAQ:MRKR - TradingView
GX1 Forecast — Price Target — Prediction for 2027 - TradingView
SGMOQ Stock Price and Chart — OTC:SGMOQ - TradingView
Exploring High Growth Tech Stocks In The US Market June 2026 - simplywall.st
Marker Therapeutics Inc. Q1 2026 Earnings: Narrower-Than-Expected Loss Amid Pre-Revenue StatusMargin Improvement Report - dars.gov.et
Marker Therapeutics (MRKR) Slides 1.48% as Stock Hovers Near Key Support LevelValue Area Low - dars.gov.et
Marker Therapeutics Inc (MRKR) Institutional Confidence - TradingKey
Marker Therapeutics Inc (MRKR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Marker Therapeutics Inc (MRKR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Marker Therapeutics Holds Steady Near Key Support and Resistance LevelsADD Alert - newsline.com
Exploring 3 High Growth Tech Stocks in US Market - simplywall.st
Marker Therapeutics (MRKR) Q1 2026 Earnings: Narrower Loss Beats Estimates, Stock Inches HigherEPS Growth Report - newsline.com
MRKR Q1 2026 Earnings: Narrower-than-expected loss highlights cost management amid pipeline progressGuidance vs Actual - newsline.com
Marker Therapeutics (MRKR) Holds Steady Above Support as Biotech Sector Shows Mixed SignalsHigh Dividend Factor - newsline.com
Oruka Therapeutics, Inc. (ORKA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):